TLR Adaptor Protein MYD88 Mediates Sensitivity to HDAC Inhibitors via a Cytokine-Dependent Mechanism

December 10, 2016

TLR Adaptor Protein MYD88 Mediates Sensitivity to HDAC Inhibitors via a Cytokine-Dependent Mechanism

Cancer Research – December 2016

New-et-al-Cancer-Research-2016

Share This Post

LinkedInMessengerWhatsApp

More Posts

Interim Phase 2 Results Suggest Zabadinostat Combination Improves Overall Survival in Advanced Liver Cancer

February 26, 2025

IngenOx Therapeutics Chief Medical Officer Meets Chinese Premier to Advance International Anti-Cancer Cooperation

February 10, 2025

IngenOx Therapeutics CMO Receives China Friendship Medal

October 21, 2024